Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Palomeras · SciRah

Researcher profile · Semantic Scholar

S. Palomeras

Share profile

S. Palomeras — researcher profile on SciRah

h-index: 9
Works: 17
Citations: 496

Most-cited papers

Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
S. Palomeras, S. Ruiz-Martínez, T. Puig
2018Molecules148 citations Open access
Semantic Scholar
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
A. Giró-Perafita, S. Palomeras, David H. Lum, A. Blancafort +6 more
2016Clinical Cancer Research77 citations Open access
Semantic Scholar
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
A. Blancafort, A. Giró-Perafita, G. Oliveras, S. Palomeras +9 more
2015PLoS ONE59 citations Open access
Semantic Scholar
Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer
S. Palomeras, Á. Díaz-Lagares, G. Viñas, F. Setien +8 more
2019Breast Cancer Research58 citations Open access
Semantic Scholar
Breast Cancer Stem Cell Culture and Enrichment Using Poly(ε-Caprolactone) Scaffolds
S. Palomeras, M. Rabionet, I. Ferrer, Ariadna Sarrats +3 more
2016Molecules45 citations Open access
Semantic Scholar
(−)-Epigallocatechin 3-Gallate Synthetic Analogues Inhibit Fatty Acid Synthase and Show Anticancer Activity in Triple Negative Breast Cancer
Joan Crous-Masó, S. Palomeras, J. Relat, Cristina Camó +4 more
2018Molecules38 citations Open access
Semantic Scholar
Trafficking and localisation to the plasma membrane of Nav1.5 promoted by the β2 subunit is defective due to a β2 mutation associated with Brugada syndrome
G. Dulsat, S. Palomeras, Eric Cortada, Helena Riuró +2 more
2017Biology of the Cell21 citations
Semantic Scholar
RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer
A. Sanz-Moreno, S. Palomeras, K. Pedersen, B. Morancho +20 more
2021Breast Cancer Research20 citations Open access
Semantic Scholar
Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models
E. Polonio-Alcalá, S. Palomeras, Daniel Torres-Oteros, J. Relat +5 more
2020Cancers20 citations Open access
Semantic Scholar
Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma
E. Polonio-Alcalá, M. Rabionet, S. Ruiz-Martínez, S. Palomeras +5 more
2021Cancers8 citations Open access
Semantic Scholar
33PDNA methylation signature to identify trastuzumab response in HER2 breast cancer models
S. Palomeras, Á. Lagares, A. Blancafort, Ariadna Sarrats +6 more
20172 citations Open access
Semantic Scholar
Three-dimensional hydrophobic platforms for in vitro tumoroid culture
D. Lobo, P. Ginestra, E. Ceretti, J. Ciurana +2 more
2022Procedia CIRP1 citations Open access
Semantic Scholar
3P AZ12756122, a novel fatty acid synthase (FASN) inhibitor, reduces resistance properties in gefitinib- and osimertinib-resistant EGFR-mutated non-small cell lung cancer models
E. Polonio, S. Palomeras, R. Porta-Balanya, J. Bosch-Barrera +4 more
20211 citations
Semantic Scholar
Abstract 2130A: Epigenetic silencing of TGFβ1, BCL6, KILLIN and CTSZ is related to trastuzumab resistance in HER2-positive breast cancer models
S. Palomeras, Á. Díaz-Lagares, Sarrats Ariadna, Crujeiras Ana Belen +5 more
20161 citations
Semantic Scholar
1979MO Inhibition of fatty acid synthase (FASN) activity induces cytotoxicity on gefitinib- and osimertinib-resistant EGFR-mutated non-small cell lung cancer cells
E. Polonio, S. Palomeras, J. Bosch-Barrera, R. Porta-Balanya +4 more
20200 citations Open access
Semantic Scholar
69P TGFBI promoter methylation validation as an epigenetic biomarker for trastuzumab resistance in HER2+ breast cancer patients cohort
H. Pla, Á. Díaz-Lagares, A. Hernandez, G. Oliveras +5 more
20200 citations Open access
Semantic Scholar
Abstract 3323: Breast cancer stem cell culture and enrichment using poly(ε-caprolactone) 3D scaffolds
M. Rabionet, S. Palomeras, I. Ferrer, Ariadna Sarrats +4 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Puig×16
Invite
T. Puig — researcher profile on SciRah
J. Ciurana×7
Invite
J. Ciurana — researcher profile on SciRah
S. Ruiz-Martínez×5
Invite
S. Ruiz-Martínez — researcher profile on SciRah
M. Rabionet×5
Invite
M. Rabionet — researcher profile on SciRah

×4

Invite

G. Viñas — researcher profile on SciRah

Invite

G. Oliveras — researcher profile on SciRah

Ariadna Sarrats×4

Invite

Ariadna Sarrats — researcher profile on SciRah

Invite

M. Esteller — researcher profile on SciRah

A. Giró-Perafita×3

Invite

A. Giró-Perafita — researcher profile on SciRah

A. Blancafort×3

Invite

A. Blancafort — researcher profile on SciRah

Invite

A. Welm — researcher profile on SciRah

Á. Díaz-Lagares×3

Invite

Á. Díaz-Lagares — researcher profile on SciRah